Hotcongo, my calculations suggest that Milford still held over 6 million shares at 17 July but that’s just my calculation and I could be wrong. Perhaps someone else might be able to confirm if that’s correct or not.
I don’t know if or to what extent Milford has sold down since. The only evidence I can find is that they still had some holding in NEU at 30/09/24. Again, perhaps someone else might be able to shed more light on this.
What I do know is that over 52 million NEU shares have been traded between 18 July and when the Buy Back commenced on 2 December and the share price fell 44% in the same period from $22.14 to $12.47.
During this period, Neuren has announced:
Rare paediatric disease designation for NNZ-2591 in PMS
Positive Phase 2 results for NNZ-2591 in Angelman syndrome
Positive EOP2 meeting with FDA
Sale of PRV with US$50m proceeds to Neuren
Announcement of Buy Back
NEU Price at posting:
$13.44 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)